Back to Search
Start Over
POSB19 Matching-Adjusted Indirect Comparison of Trastuzumab Deruxtecan vs. Eribulin, Capecitabine, and Vinorelbine for Treating Human Epidermal Growth Factor Receptor 2-Positive Unresectable or Metastatic Breast Cancer after Two or More Anti-Human Epidermal Growth Factor Receptor 2-Positive Therapies
- Source :
-
Value in Health . 2022 Supplement, Vol. 25 Issue 1, pS28-S28. 1p. - Publication Year :
- 2022
- Subjects :
- *METASTATIC breast cancer
*ERIBULIN
*VINORELBINE
*EPIDERMAL growth factor receptors
Subjects
Details
- Language :
- English
- ISSN :
- 10983015
- Volume :
- 25
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Value in Health
- Publication Type :
- Academic Journal
- Accession number :
- 154761449
- Full Text :
- https://doi.org/10.1016/j.jval.2021.11.129